SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System
Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio…
28,442$
-3,26%
Echtzeit-Aktienkurs Surmodics Inc.
Bid:
Ask:
Nachrichten zur Surmodics Inc. Aktie
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge
The FTC has blocked GTCRs $627M acquisition of SRDX, citing anti-competitive concerns. Surmodics has responded to the challenge and plans…
FTC sues to block private equity firms deal to buy medical device coatings maker Surmodics
The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics acquisition by private equity firm…
SurModics (SRDX) May Find a Bottom Soon, Heres Why You Should Buy the Stock Now
SurModics (SRDX) appears to have found support after losing some value lately, as indicated by the formation of a hammer…
Surmodics jumps 18% on acquisition by GTCR
…
Heres Why You Should Hold Surmodics (SRDX) Stock for Now
Surmodics (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.…
Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript
…
Heres Why You Should Hold Surmodics (SRDX) Stock for Now
Surmodics (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.…